The global Veterinary Vaccines market was valued at US$ 8544.4 million in 2022 and is projected to reach US$ 12710 million by 2029, at a CAGR of 5.8% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The USA market for Global Veterinary Vaccines market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The China market for Global Veterinary Vaccines market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The Europe market for Global Veterinary Vaccines market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
Vaccines are products designed to trigger protective immune responses and prepare the immune system to fight future infections from disease-causing agents. Vaccines stimulate the immune systems production of antibodies that identify and destroy disease-causing organisms that enter the body. Vaccines provide immunity against one or several diseases that can lessen the severity or prevent certain diseases altogether. In this report, we study the vaccine used for animals.
This report aims to provide a comprehensive presentation of the global market for Veterinary Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Veterinary Vaccines. This report contains market size and forecasts of Veterinary Vaccines in global, including the following market information:
- Global Veterinary Vaccines Market Revenue, 2018-2023, 2024-2030, ($ millions)
- Global top five companies in 2022 (%)
Global Veterinary Vaccine key players include Merck, Boehringer Ingelheim, Zoetis, Ceva, Elanco, etc. Global top five manufacturers hold a share about 75%. North America and Asia Pacific is the largest market, both with a share about 30%, followed by Europe, with a share about 25 percent. In terms of product, Live Attenuated Vaccines is the largest segment, with a share about 60%. And in terms of application, the largest application is Dog & Cat, followed by Livestock, Swine, Chicken, etc.
We surveyed the Veterinary Vaccines companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Veterinary Vaccines Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Veterinary Vaccines Market Segment Percentages, by Type, 2022 (%)
- Inactivated Vaccines
- Live Attenuated Vaccines
- Conjugate Vaccines
- Toxoid Vaccines
- Recombinant Vaccines
- DNA Vaccines
- Others
Global Veterinary Vaccines Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Veterinary Vaccines Market Segment Percentages, by Application, 2022 (%)
- Veterinary Clinic
- Veterinary Hospital
- Veterinary Research Institute
- Retail Pharmacy
- Others
Global Veterinary Vaccines Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Veterinary Vaccines Market Segment Percentages, By Region and Country, 2022 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Veterinary Vaccines revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Veterinary Vaccines revenues share in global market, 2022 (%)
key players include:
- Elanco
- Merck
- Merial
- Zoetis
- Advaxis
- AmpliPhi Biosciences
- Aratana Therapeutics
- ARKO Labs
- Bayer
- CanFel Therapeutics
- Ceva Animal Health
- Colorado Serum
- Epitopix
- Genus
- Hygieia Biological Laboratories
- ImmuCell
- Nexvet
- Nuovo Biologics
- UBI
- Valneva
- Vetoquinol
- Virbac
Outline of Major Chapters:
Chapter 1: Introduces the definition of Veterinary Vaccines, market overview.
Chapter 2: Global Veterinary Vaccines market size in revenue.
Chapter 3: Detailed analysis of Veterinary Vaccines company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments
by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments
by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Veterinary Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Veterinary Vaccines Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Veterinary Vaccines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Veterinary Vaccines Overall Market Size
2.1 Global Veterinary Vaccines Market Size: 2022 VS 2030
2.2 Global Veterinary Vaccines Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Veterinary Vaccines Players in Global Market
3.2 Top Global Veterinary Vaccines Companies Ranked by Revenue
3.3 Global Veterinary Vaccines Revenue by Companies
3.4 Top 3 and Top 5 Veterinary Vaccines Companies in Global Market, by Revenue in 2022
3.5 Global Companies Veterinary Vaccines Product Type
3.6 Tier 1, Tier 2 and Tier 3 Veterinary Vaccines Players in Global Market
3.6.1 List of Global Tier 1 Veterinary Vaccines Companies
3.6.2 List of Global Tier 2 and Tier 3 Veterinary Vaccines Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Veterinary Vaccines Market Size Markets, 2022 & 2030
4.1.2 Inactivated Vaccines
4.1.3 Live Attenuated Vaccines
4.1.4 Conjugate Vaccines
4.1.5 Toxoid Vaccines
4.1.6 Recombinant Vaccines
4.1.7 DNA Vaccines
4.1.8 Others
4.2 By Type - Global Veterinary Vaccines Revenue & Forecasts
4.2.1 By Type - Global Veterinary Vaccines Revenue, 2018-2023
4.2.2 By Type - Global Veterinary Vaccines Revenue, 2024-2030
4.2.3 By Type - Global Veterinary Vaccines Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Veterinary Vaccines Market Size, 2022 & 2030
5.1.2 Veterinary Clinic
5.1.3 Veterinary Hospital
5.1.4 Veterinary Research Institute
5.1.5 Retail Pharmacy
5.1.6 Others
5.2 By Application - Global Veterinary Vaccines Revenue & Forecasts
5.2.1 By Application - Global Veterinary Vaccines Revenue, 2018-2023
5.2.2 By Application - Global Veterinary Vaccines Revenue, 2024-2030
5.2.3 By Application - Global Veterinary Vaccines Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Veterinary Vaccines Market Size, 2022 & 2030
6.2 By Region - Global Veterinary Vaccines Revenue & Forecasts
6.2.1 By Region - Global Veterinary Vaccines Revenue, 2018-2023
6.2.2 By Region - Global Veterinary Vaccines Revenue, 2024-2030
6.2.3 By Region - Global Veterinary Vaccines Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Veterinary Vaccines Revenue, 2018-2030
6.3.2 US Veterinary Vaccines Market Size, 2018-2030
6.3.3 Canada Veterinary Vaccines Market Size, 2018-2030
6.3.4 Mexico Veterinary Vaccines Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Veterinary Vaccines Revenue, 2018-2030
6.4.2 Germany Veterinary Vaccines Market Size, 2018-2030
6.4.3 France Veterinary Vaccines Market Size, 2018-2030
6.4.4 U.K. Veterinary Vaccines Market Size, 2018-2030
6.4.5 Italy Veterinary Vaccines Market Size, 2018-2030
6.4.6 Russia Veterinary Vaccines Market Size, 2018-2030
6.4.7 Nordic Countries Veterinary Vaccines Market Size, 2018-2030
6.4.8 Benelux Veterinary Vaccines Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Veterinary Vaccines Revenue, 2018-2030
6.5.2 China Veterinary Vaccines Market Size, 2018-2030
6.5.3 Japan Veterinary Vaccines Market Size, 2018-2030
6.5.4 South Korea Veterinary Vaccines Market Size, 2018-2030
6.5.5 Southeast Asia Veterinary Vaccines Market Size, 2018-2030
6.5.6 India Veterinary Vaccines Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Veterinary Vaccines Revenue, 2018-2030
6.6.2 Brazil Veterinary Vaccines Market Size, 2018-2030
6.6.3 Argentina Veterinary Vaccines Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Veterinary Vaccines Revenue, 2018-2030
6.7.2 Turkey Veterinary Vaccines Market Size, 2018-2030
6.7.3 Israel Veterinary Vaccines Market Size, 2018-2030
6.7.4 Saudi Arabia Veterinary Vaccines Market Size, 2018-2030
6.7.5 UAE Veterinary Vaccines Market Size, 2018-2030
7 Veterinary Vaccines Companies Profiles
7.1 Elanco
7.1.1 Elanco Company Summary
7.1.2 Elanco Business Overview
7.1.3 Elanco Veterinary Vaccines Major Product Offerings
7.1.4 Elanco Veterinary Vaccines Revenue in Global Market (2018-2023)
7.1.5 Elanco Key News & Latest Developments
7.2 Merck
7.2.1 Merck Company Summary
7.2.2 Merck Business Overview
7.2.3 Merck Veterinary Vaccines Major Product Offerings
7.2.4 Merck Veterinary Vaccines Revenue in Global Market (2018-2023)
7.2.5 Merck Key News & Latest Developments
7.3 Merial
7.3.1 Merial Company Summary
7.3.2 Merial Business Overview
7.3.3 Merial Veterinary Vaccines Major Product Offerings
7.3.4 Merial Veterinary Vaccines Revenue in Global Market (2018-2023)
7.3.5 Merial Key News & Latest Developments
7.4 Zoetis
7.4.1 Zoetis Company Summary
7.4.2 Zoetis Business Overview
7.4.3 Zoetis Veterinary Vaccines Major Product Offerings
7.4.4 Zoetis Veterinary Vaccines Revenue in Global Market (2018-2023)
7.4.5 Zoetis Key News & Latest Developments
7.5 Advaxis
7.5.1 Advaxis Company Summary
7.5.2 Advaxis Business Overview
7.5.3 Advaxis Veterinary Vaccines Major Product Offerings
7.5.4 Advaxis Veterinary Vaccines Revenue in Global Market (2018-2023)
7.5.5 Advaxis Key News & Latest Developments
7.6 AmpliPhi Biosciences
7.6.1 AmpliPhi Biosciences Company Summary
7.6.2 AmpliPhi Biosciences Business Overview
7.6.3 AmpliPhi Biosciences Veterinary Vaccines Major Product Offerings
7.6.4 AmpliPhi Biosciences Veterinary Vaccines Revenue in Global Market (2018-2023)
7.6.5 AmpliPhi Biosciences Key News & Latest Developments
7.7 Aratana Therapeutics
7.7.1 Aratana Therapeutics Company Summary
7.7.2 Aratana Therapeutics Business Overview
7.7.3 Aratana Therapeutics Veterinary Vaccines Major Product Offerings
7.7.4 Aratana Therapeutics Veterinary Vaccines Revenue in Global Market (2018-2023)
7.7.5 Aratana Therapeutics Key News & Latest Developments
7.8 ARKO Labs
7.8.1 ARKO Labs Company Summary
7.8.2 ARKO Labs Business Overview
7.8.3 ARKO Labs Veterinary Vaccines Major Product Offerings
7.8.4 ARKO Labs Veterinary Vaccines Revenue in Global Market (2018-2023)
7.8.5 ARKO Labs Key News & Latest Developments
7.9 Bayer
7.9.1 Bayer Company Summary
7.9.2 Bayer Business Overview
7.9.3 Bayer Veterinary Vaccines Major Product Offerings
7.9.4 Bayer Veterinary Vaccines Revenue in Global Market (2018-2023)
7.9.5 Bayer Key News & Latest Developments
7.10 CanFel Therapeutics
7.10.1 CanFel Therapeutics Company Summary
7.10.2 CanFel Therapeutics Business Overview
7.10.3 CanFel Therapeutics Veterinary Vaccines Major Product Offerings
7.10.4 CanFel Therapeutics Veterinary Vaccines Revenue in Global Market (2018-2023)
7.10.5 CanFel Therapeutics Key News & Latest Developments
7.11 Ceva Animal Health
7.11.1 Ceva Animal Health Company Summary
7.11.2 Ceva Animal Health Business Overview
7.11.3 Ceva Animal Health Veterinary Vaccines Major Product Offerings
7.11.4 Ceva Animal Health Veterinary Vaccines Revenue in Global Market (2018-2023)
7.11.5 Ceva Animal Health Key News & Latest Developments
7.12 Colorado Serum
7.12.1 Colorado Serum Company Summary
7.12.2 Colorado Serum Business Overview
7.12.3 Colorado Serum Veterinary Vaccines Major Product Offerings
7.12.4 Colorado Serum Veterinary Vaccines Revenue in Global Market (2018-2023)
7.12.5 Colorado Serum Key News & Latest Developments
7.13 Epitopix
7.13.1 Epitopix Company Summary
7.13.2 Epitopix Business Overview
7.13.3 Epitopix Veterinary Vaccines Major Product Offerings
7.13.4 Epitopix Veterinary Vaccines Revenue in Global Market (2018-2023)
7.13.5 Epitopix Key News & Latest Developments
7.14 Genus
7.14.1 Genus Company Summary
7.14.2 Genus Business Overview
7.14.3 Genus Veterinary Vaccines Major Product Offerings
7.14.4 Genus Veterinary Vaccines Revenue in Global Market (2018-2023)
7.14.5 Genus Key News & Latest Developments
7.15 Hygieia Biological Laboratories
7.15.1 Hygieia Biological Laboratories Company Summary
7.15.2 Hygieia Biological Laboratories Business Overview
7.15.3 Hygieia Biological Laboratories Veterinary Vaccines Major Product Offerings
7.15.4 Hygieia Biological Laboratories Veterinary Vaccines Revenue in Global Market (2018-2023)
7.15.5 Hygieia Biological Laboratories Key News & Latest Developments
7.16 ImmuCell
7.16.1 ImmuCell Company Summary
7.16.2 ImmuCell Business Overview
7.16.3 ImmuCell Veterinary Vaccines Major Product Offerings
7.16.4 ImmuCell Veterinary Vaccines Revenue in Global Market (2018-2023)
7.16.5 ImmuCell Key News & Latest Developments
7.17 Nexvet
7.17.1 Nexvet Company Summary
7.17.2 Nexvet Business Overview
7.17.3 Nexvet Veterinary Vaccines Major Product Offerings
7.17.4 Nexvet Veterinary Vaccines Revenue in Global Market (2018-2023)
7.17.5 Nexvet Key News & Latest Developments
7.18 Nuovo Biologics
7.18.1 Nuovo Biologics Company Summary
7.18.2 Nuovo Biologics Business Overview
7.18.3 Nuovo Biologics Veterinary Vaccines Major Product Offerings
7.18.4 Nuovo Biologics Veterinary Vaccines Revenue in Global Market (2018-2023)
7.18.5 Nuovo Biologics Key News & Latest Developments
7.19 UBI
7.19.1 UBI Company Summary
7.19.2 UBI Business Overview
7.19.3 UBI Veterinary Vaccines Major Product Offerings
7.19.4 UBI Veterinary Vaccines Revenue in Global Market (2018-2023)
7.19.5 UBI Key News & Latest Developments
7.20 Valneva
7.20.1 Valneva Company Summary
7.20.2 Valneva Business Overview
7.20.3 Valneva Veterinary Vaccines Major Product Offerings
7.20.4 Valneva Veterinary Vaccines Revenue in Global Market (2018-2023)
7.20.5 Valneva Key News & Latest Developments
7.21 Vetoquinol
7.21.1 Vetoquinol Company Summary
7.21.2 Vetoquinol Business Overview
7.21.3 Vetoquinol Veterinary Vaccines Major Product Offerings
7.21.4 Vetoquinol Veterinary Vaccines Revenue in Global Market (2018-2023)
7.21.5 Vetoquinol Key News & Latest Developments
7.22 Virbac
7.22.1 Virbac Company Summary
7.22.2 Virbac Business Overview
7.22.3 Virbac Veterinary Vaccines Major Product Offerings
7.22.4 Virbac Veterinary Vaccines Revenue in Global Market (2018-2023)
7.22.5 Virbac Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Veterinary Vaccines Market Opportunities & Trends in Global Market
Table 2. Veterinary Vaccines Market Drivers in Global Market
Table 3. Veterinary Vaccines Market Restraints in Global Market
Table 4. Key Players of Veterinary Vaccines in Global Market
Table 5. Top Veterinary Vaccines Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Veterinary Vaccines Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Veterinary Vaccines Revenue Share by Companies, 2018-2023
Table 8. Global Companies Veterinary Vaccines Product Type
Table 9. List of Global Tier 1 Veterinary Vaccines Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Veterinary Vaccines Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Veterinary Vaccines Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Veterinary Vaccines Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Veterinary Vaccines Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Veterinary Vaccines Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Veterinary Vaccines Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Veterinary Vaccines Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Veterinary Vaccines Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Veterinary Vaccines Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Veterinary Vaccines Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Veterinary Vaccines Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Veterinary Vaccines Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Veterinary Vaccines Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Veterinary Vaccines Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Veterinary Vaccines Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Veterinary Vaccines Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Veterinary Vaccines Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Veterinary Vaccines Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Veterinary Vaccines Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Veterinary Vaccines Revenue, (US$, Mn), 2024-2030
Table 30. Elanco Company Summary
Table 31. Elanco Veterinary Vaccines Product Offerings
Table 32. Elanco Veterinary Vaccines Revenue (US$, Mn) & (2018-2023)
Table 33. Elanco Key News & Latest Developments
Table 34. Merck Company Summary
Table 35. Merck Veterinary Vaccines Product Offerings
Table 36. Merck Veterinary Vaccines Revenue (US$, Mn) & (2018-2023)
Table 37. Merck Key News & Latest Developments
Table 38. Merial Company Summary
Table 39. Merial Veterinary Vaccines Product Offerings
Table 40. Merial Veterinary Vaccines Revenue (US$, Mn) & (2018-2023)
Table 41. Merial Key News & Latest Developments
Table 42. Zoetis Company Summary
Table 43. Zoetis Veterinary Vaccines Product Offerings
Table 44. Zoetis Veterinary Vaccines Revenue (US$, Mn) & (2018-2023)
Table 45. Zoetis Key News & Latest Developments
Table 46. Advaxis Company Summary
Table 47. Advaxis Veterinary Vaccines Product Offerings
Table 48. Advaxis Veterinary Vaccines Revenue (US$, Mn) & (2018-2023)
Table 49. Advaxis Key News & Latest Developments
Table 50. AmpliPhi Biosciences Company Summary
Table 51. AmpliPhi Biosciences Veterinary Vaccines Product Offerings
Table 52. AmpliPhi Biosciences Veterinary Vaccines Revenue (US$, Mn) & (2018-2023)
Table 53. AmpliPhi Biosciences Key News & Latest Developments
Table 54. Aratana Therapeutics Company Summary
Table 55. Aratana Therapeutics Veterinary Vaccines Product Offerings
Table 56. Aratana Therapeutics Veterinary Vaccines Revenue (US$, Mn) & (2018-2023)
Table 57. Aratana Therapeutics Key News & Latest Developments
Table 58. ARKO Labs Company Summary
Table 59. ARKO Labs Veterinary Vaccines Product Offerings
Table 60. ARKO Labs Veterinary Vaccines Revenue (US$, Mn) & (2018-2023)
Table 61. ARKO Labs Key News & Latest Developments
Table 62. Bayer Company Summary
Table 63. Bayer Veterinary Vaccines Product Offerings
Table 64. Bayer Veterinary Vaccines Revenue (US$, Mn) & (2018-2023)
Table 65. Bayer Key News & Latest Developments
Table 66. CanFel Therapeutics Company Summary
Table 67. CanFel Therapeutics Veterinary Vaccines Product Offerings
Table 68. CanFel Therapeutics Veterinary Vaccines Revenue (US$, Mn) & (2018-2023)
Table 69. CanFel Therapeutics Key News & Latest Developments
Table 70. Ceva Animal Health Company Summary
Table 71. Ceva Animal Health Veterinary Vaccines Product Offerings
Table 72. Ceva Animal Health Veterinary Vaccines Revenue (US$, Mn) & (2018-2023)
Table 73. Ceva Animal Health Key News & Latest Developments
Table 74. Colorado Serum Company Summary
Table 75. Colorado Serum Veterinary Vaccines Product Offerings
Table 76. Colorado Serum Veterinary Vaccines Revenue (US$, Mn) & (2018-2023)
Table 77. Colorado Serum Key News & Latest Developments
Table 78. Epitopix Company Summary
Table 79. Epitopix Veterinary Vaccines Product Offerings
Table 80. Epitopix Veterinary Vaccines Revenue (US$, Mn) & (2018-2023)
Table 81. Epitopix Key News & Latest Developments
Table 82. Genus Company Summary
Table 83. Genus Veterinary Vaccines Product Offerings
Table 84. Genus Veterinary Vaccines Revenue (US$, Mn) & (2018-2023)
Table 85. Genus Key News & Latest Developments
Table 86. Hygieia Biological Laboratories Company Summary
Table 87. Hygieia Biological Laboratories Veterinary Vaccines Product Offerings
Table 88. Hygieia Biological Laboratories Veterinary Vaccines Revenue (US$, Mn) & (2018-2023)
Table 89. Hygieia Biological Laboratories Key News & Latest Developments
Table 90. ImmuCell Company Summary
Table 91. ImmuCell Veterinary Vaccines Product Offerings
Table 92. ImmuCell Veterinary Vaccines Revenue (US$, Mn) & (2018-2023)
Table 93. ImmuCell Key News & Latest Developments
Table 94. Nexvet Company Summary
Table 95. Nexvet Veterinary Vaccines Product Offerings
Table 96. Nexvet Veterinary Vaccines Revenue (US$, Mn) & (2018-2023)
Table 97. Nexvet Key News & Latest Developments
Table 98. Nuovo Biologics Company Summary
Table 99. Nuovo Biologics Veterinary Vaccines Product Offerings
Table 100. Nuovo Biologics Veterinary Vaccines Revenue (US$, Mn) & (2018-2023)
Table 101. Nuovo Biologics Key News & Latest Developments
Table 102. UBI Company Summary
Table 103. UBI Veterinary Vaccines Product Offerings
Table 104. UBI Veterinary Vaccines Revenue (US$, Mn) & (2018-2023)
Table 105. UBI Key News & Latest Developments
Table 106. Valneva Company Summary
Table 107. Valneva Veterinary Vaccines Product Offerings
Table 108. Valneva Veterinary Vaccines Revenue (US$, Mn) & (2018-2023)
Table 109. Valneva Key News & Latest Developments
Table 110. Vetoquinol Company Summary
Table 111. Vetoquinol Veterinary Vaccines Product Offerings
Table 112. Vetoquinol Veterinary Vaccines Revenue (US$, Mn) & (2018-2023)
Table 113. Vetoquinol Key News & Latest Developments
Table 114. Virbac Company Summary
Table 115. Virbac Veterinary Vaccines Product Offerings
Table 116. Virbac Veterinary Vaccines Revenue (US$, Mn) & (2018-2023)
Table 117. Virbac Key News & Latest Developments
List of Figures
Figure 1. Veterinary Vaccines Segment by Type in 2022
Figure 2. Veterinary Vaccines Segment by Application in 2022
Figure 3. Global Veterinary Vaccines Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Veterinary Vaccines Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Veterinary Vaccines Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Veterinary Vaccines Revenue in 2022
Figure 8. By Type - Global Veterinary Vaccines Revenue Market Share, 2018-2030
Figure 9. By Application - Global Veterinary Vaccines Revenue Market Share, 2018-2030
Figure 10. By Type - Global Veterinary Vaccines Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Veterinary Vaccines Revenue Market Share, 2018-2030
Figure 12. By Application - Global Veterinary Vaccines Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Veterinary Vaccines Revenue Market Share, 2018-2030
Figure 14. By Region - Global Veterinary Vaccines Revenue Market Share, 2018-2030
Figure 15. By Country - North America Veterinary Vaccines Revenue Market Share, 2018-2030
Figure 16. US Veterinary Vaccines Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Veterinary Vaccines Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Veterinary Vaccines Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Veterinary Vaccines Revenue Market Share, 2018-2030
Figure 20. Germany Veterinary Vaccines Revenue, (US$, Mn), 2018-2030
Figure 21. France Veterinary Vaccines Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Veterinary Vaccines Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Veterinary Vaccines Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Veterinary Vaccines Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Veterinary Vaccines Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Veterinary Vaccines Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Veterinary Vaccines Revenue Market Share, 2018-2030
Figure 28. China Veterinary Vaccines Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Veterinary Vaccines Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Veterinary Vaccines Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Veterinary Vaccines Revenue, (US$, Mn), 2018-2030
Figure 32. India Veterinary Vaccines Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Veterinary Vaccines Revenue Market Share, 2018-2030
Figure 34. Brazil Veterinary Vaccines Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Veterinary Vaccines Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Veterinary Vaccines Revenue Market Share, 2018-2030
Figure 37. Turkey Veterinary Vaccines Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Veterinary Vaccines Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Veterinary Vaccines Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Veterinary Vaccines Revenue, (US$, Mn), 2018-2030
Figure 41. Elanco Veterinary Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Merck Veterinary Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Merial Veterinary Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Zoetis Veterinary Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Advaxis Veterinary Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. AmpliPhi Biosciences Veterinary Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Aratana Therapeutics Veterinary Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. ARKO Labs Veterinary Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Bayer Veterinary Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. CanFel Therapeutics Veterinary Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Ceva Animal Health Veterinary Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Colorado Serum Veterinary Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Epitopix Veterinary Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Genus Veterinary Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Hygieia Biological Laboratories Veterinary Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. ImmuCell Veterinary Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 57. Nexvet Veterinary Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 58. Nuovo Biologics Veterinary Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 59. UBI Veterinary Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 60. Valneva Veterinary Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 61. Vetoquinol Veterinary Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 62. Virbac Veterinary Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
